FDA approves generic Singulair for Asthma - 05-Aug-2012

The FDA has approved the first generic versions of Singulair (montelukast sodium)from AstraZeneca for use in adults and children to control Asthma symptoms and to help relieve symptoms of indoor and outdoor allergies. Apotex Inc., Aurobindo Pharma, Endo Pharmaceuticals, Glenmark Generics, Kudco Ireland Inc., Mylan Inc., Roxane Laboratories, Sandoz Inc., Teva Pharmaceuticals Inc., and Torrent Pharmaceuticals have gained FDA approval for generic montelukast tablets. Apotex, Aurobindo, Endo, Kudco, Mylan, Roxane, Sandoz, Teva, and Torrent have received approval for chewable tablets. Teva has received approval for the oral granule form.

Related News

Related Respiratory Information

Related Respiratory Drugs

Back to top

Latest News

10 May 2015
18 May 2013
18 May 2013